83
Views
22
CrossRef citations to date
0
Altmetric
Review

Bevacizumab in high-grade gliomas: a review of its uses, toxicity assessment, and future treatment challenges

, , &
Pages 371-389 | Published online: 15 Apr 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ying-dong Cheng, Hua Yang, Guo-qing Chen & Zhi-cao Zhang. (2013) Molecularly targeted drugs for metastatic colorectal cancer. Drug Design, Development and Therapy 7, pages 1315-1322.
Read now

Articles from other publishers (21)

Xin Huang, Shuyou Shi, Hongrui Wang, Tiesuo Zhao, Yibo Wang, Sihua Huang, Yingying Su, Chunyan Zhao & Ming Yang. (2023) Advances in antibody-based drugs and their delivery through the blood-brain barrier for targeted therapy and immunotherapy of gliomas. International Immunopharmacology 117, pages 109990.
Crossref
Mateusz Cieśluk, Katarzyna Pogoda, Ewelina Piktel, Urszula Wnorowska, Piotr Deptuła & Robert Bucki. (2022) Mechanical Properties of the Extracellular Environment of Human Brain Cells Drive the Effectiveness of Drugs in Fighting Central Nervous System Cancers. Brain Sciences 12:7, pages 927.
Crossref
Vinitha Rani, Jayachandran Venkatesan & Ashwini Prabhu. (2021) Gold nanocrystals as potential inhibitors of tumor angiogenesis: implications in diagnosis and drug delivery. Journal of Nanoparticle Research 23:7.
Crossref
N. García-Romero, I. Palacín-Aliana, R. Madurga, J. Carrión-Navarro, S. Esteban-Rubio, B. Jiménez, A. Collazo, F. Pérez-Rodríguez, A. Ortiz de Mendivil, C. Fernández-Carballal, S. García-Duque, J. Diamantopoulos-Fernández, C. Belda-Iniesta, R. Prat-Acín, P. Sánchez-Gómez, E. Calvo & A. Ayuso-Sacido. (2020) Bevacizumab dose adjustment to improve clinical outcomes of glioblastoma. BMC Medicine 18:1.
Crossref
Bibi Faiza & Syed Qaiser Shah. (2020) Synthesis of 99mTc-p-SCN-Bzl-TCMC-bevacizumab for vascular endothelial growth factor (VEGF) receptor imaging using ovarian cancer model. Journal of Radioanalytical and Nuclear Chemistry 325:1, pages 147-154.
Crossref
Anupriya Anand, Abimanyu Sugumaran & Damodharan Narayanasamy. (2019) Brain targeted delivery of anticancer drugs: prospective approach using solid lipid nanoparticles. IET Nanobiotechnology 13:4, pages 353-362.
Crossref
Montserrat Lara-Velazquez, Rawan Al-Kharboosh, Stephanie Jeanneret, Carla Vazquez-Ramos, Deependra Mahato, Daryoush Tavanaiepour, Gazanfar Rahmathulla & Alfredo Quinones-Hinojosa. (2017) Advances in Brain Tumor Surgery for Glioblastoma in Adults. Brain Sciences 7:12, pages 166.
Crossref
Rongrong Zhu, Zhaoqi Wang, Peng Liang, Xiaolie He, Xizhen Zhuang, Ruiqi Huang, Mei Wang, Qigang Wang, Yechang Qian & Shilong Wang. (2017) Efficient VEGF targeting delivery of DOX using Bevacizumab conjugated SiO2@LDH for anti-neuroblastoma therapy. Acta Biomaterialia 63, pages 163-180.
Crossref
Elizabeth J Hovey, Kathryn M Field, Mark A Rosenthal, Elizabeth H Barnes, Lawrence Cher, Anna K Nowak, Helen Wheeler, Kate Sawkins, Ann Livingstone, Pramit Phal, Christine Goh & John Simes. (2017) Continuing or ceasing bevacizumab beyond progression in recurrent glioblastoma: an exploratory randomized phase II trial. Neuro-Oncology Practice 4:3, pages 171-181.
Crossref
Reinhardt Krcek, Veronika Matschke, Verena Theis, Irenäus Anton Adamietz, Helmut Bühler & Carsten Theiss. (2017) Vascular Endothelial Growth Factor, Irradiation, and Axitinib Have Diverse Effects on Motility and Proliferation of Glioblastoma Multiforme Cells. Frontiers in Oncology 7.
Crossref
Thangirala Sudha, Dhruba J. Bharali, Stewart Sell, Noureldien H. E. Darwish, Paul J. Davis & Shaker A. Mousa. (2017) Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts. Hormones and Cancer 8:3, pages 157-165.
Crossref
P. D. Delgado-López & E. M. Corrales-García. (2016) Survival in glioblastoma: a review on the impact of treatment modalities. Clinical and Translational Oncology 18:11, pages 1062-1071.
Crossref
ZHIYUN YU, GANG ZHAO, ZHONGHUA ZHANG, YUNQIAN LI, YONG CHEN, NAN WANG, ZHONGYING ZHAO & GUIFANG XIE. (2016) Efficacy and safety of bevacizumab for the treatment of glioblastoma. Experimental and Therapeutic Medicine 11:2, pages 371-380.
Crossref
Lily Liu, Haijia Yu, Xin Huang, Hongzhi Tan, Song Li, Yan Luo, Li Zhang, Sumei Jiang, Huifeng Jia, Yao Xiong, Ruliang Zhang, Yi Huang, Charles C Chu & Wenzhi Tian. (2015) A novel engineered VEGF blocker with an excellent pharmacokinetic profile and robust anti-tumor activity. BMC Cancer 15:1.
Crossref
Luigi Battaglia, Marina Gallarate, Elena Peira, Daniela Chirio, Ilaria Solazzi, Susanna Marzia Adele Giordano, Casimiro Luca Gigliotti, Chiara Riganti & Chiara Dianzani. (2015) Bevacizumab loaded solid lipid nanoparticles prepared by the coacervation technique: preliminary in vitro studies . Nanotechnology 26:25, pages 255102.
Crossref
Kathryn M. Field, Justin T. Jordan, Patrick Y. Wen, Mark A. Rosenthal & David A. Reardon. (2015) Bevacizumab and glioblastoma: Scientific review, newly reported updates, and ongoing controversies. Cancer 121:7, pages 997-1007.
Crossref
Anthony E. Rizzo & Jennifer S. Yu. 2015. Stem Cell Biology in Neoplasms of the Central Nervous System. Stem Cell Biology in Neoplasms of the Central Nervous System 85 110 .
Farina Hanif, Kahkashan Perveen, Huma Jawed, Aqeel Ahmed, Saima M Malhi, Siddiqua Jamall & Shabana U Simjee. (2014) N-(2-hydroxyphenyl)acetamide (NA-2) and Temozolomide synergistically induce apoptosis in human glioblastoma cell line U87. Cancer Cell International 14:1.
Crossref
John F. de Groot & Jacob J. Mandel. (2014) Update on Anti-angiogenic Treatment for Malignant Gliomas. Current Oncology Reports 16:4.
Crossref
Akira Matsuno, Mineko Murakami, Katsumi Hoya, Shoko M. Yamada, Shinya Miyamoto, So Yamada, Jae-Hyun Son, Hajime Nishido, Fuyuaki Ide, Hiroshi Nagashima, Mutsumi Sugaya, Toshio Hirohata, Akiko Mizutani, Hiroko Okinaga, Yudo Ishii, Shigeyuki Tahara, Akira Teramoto & R. Yoshiyuki Osamura. (2013) Molecular status of pituitary carcinoma and atypical adenoma that contributes the effectiveness of temozolomide. Medical Molecular Morphology 47:1, pages 1-7.
Crossref
Gazanfar Rahmathulla, Pablo F. Recinos, Kambiz Kamian, Alireza M. Mohammadi, Manmeet S. Ahluwalia & Gene H. Barnett. (2014) MRI-Guided Laser Interstitial Thermal Therapy in Neuro-Oncology: A Review of Its Current Clinical Applications. Oncology 87:2, pages 67-82.
Crossref